Trading high volume, page-101

I don't know why I bother, but here goes.

Drug or therapy, the point is that it is being trialled to see if it works. When I talk about risk I am not talking about adverse affects, I am talking about whether the product/ therapy actually works, investment risk. If it doesn't work, MSB is worth nothing. Do you understand ?, ..... Really do you understand that?

What does my relative have to say, this is what they have to say " it's still an area in its infancy, whilst they have trials in phase 3, many at phase 3 fail, phase 3 is the one that counts, and MSB is a long way off, still lots to happen. High risk because it is a new space.